×
About 12,938 results

ALLMedicine™ Esophagitis Center

Research & Reviews  3,316 results

Dupilumab moves forward as possible COPD treatment
https://www.mdedge.com/chestphysician/article/262062/copd/dupilumab-moves-forward-possible-copd-treatment
Heidi Splete, MDedge News

Mar 28th, 2023 - Dupilumab, a fully human monoclonal antibody, significantly improved quality of life and respiratory symptoms compared with placebo in a phase 3 trial of more than 900 adults with uncontrolled chronic obstructive pulmonary disease. In the study, k.

Esophageal Epithelium and Lamina Propria are Unevenly Involved in Eosinophilic Esophagi...
https://doi.org/10.1016/j.cgh.2023.03.014
Clinical Gastroenterology and Hepatology : the Official C... Hiremath G, Sun L et. al.

Mar 27th, 2023 - The nature of the involvement of esophageal tissue in eosinophilic esophagitis (EoE) is unclear. We estimated the intra-biopsy site agreements of the histologic scoring system (EoEHSS) scores for the grade (degree) and stage (extent) of involvemen...

To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats u...
https://doi.org/10.1016/j.lungcan.2023.03.011
Lung Cancer (Amsterdam, Netherlands); Regnery S, Katsigiannopulos E et. al.

Mar 26th, 2023 - Stereotactic radiotherapy of ultracentral lung tumors (ULT) is challenging as it may cause overdoses to sensitive mediastinal organs with severe complications. We aimed to describe long-term outcomes after stereotactic magnetic resonance (MR)-guid...

The importance of Studying Genetic Ancestry in Eosinophilic Esophagitis.
https://doi.org/10.1016/j.jaci.2023.03.010
The Journal of Allergy and Clinical Immunology; Marker KM, Mathias RA et. al.

Mar 25th, 2023 - The importance of Studying Genetic Ancestry in Eosinophilic Esophagitis.|2023|Marker KM,Mathias RA,Gignoux CR,|

A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectom...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035215
Radiation Oncology (London, England); Hong Z, Yang Z et. al.

Mar 25th, 2023 - This study aimed to compare the adverse reactions of conventional-dose and hypofractionated dose of proton therapy for breast cancer. Breast cancer patients treated with proton radiotherapy in conventional-dose or hypofractionated dose were studie...

see more →

Guidelines  14 results

Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal ...
https://doi.org/10.1016/j.gie.2022.05.013
Gastrointestinal Endoscopy; Aceves SS, Alexander JA et. al.

Aug 15th, 2022 - Endoscopy plays a critical role in caring for and evaluating the patient with eosinophilic esophagitis (EoE). Endoscopy is essential for diagnosis, assessment of response to therapy, treatment of esophageal strictures, and ongoing monitoring of pa...

AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Scre...
https://doi.org/10.1016/j.cgh.2022.06.003
Clinical Gastroenterology and Hepatology : the Official C... Muthusamy VR, Wani S et. al.

Jul 6th, 2022 - The purpose of this best practice advice (BPA) article from the Clinical Practice Update Committee of the American Gastroenterological Association is to provide an update on advances and innovation regarding the screening and surveillance of Barre...

AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Managem...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838103
Clinical Gastroenterology and Hepatology : the Official C... Yadlapati R, Gyawali CP et. al.

Feb 6th, 2022 - As many as one-half of all patients with suspected gastroesophageal reflux disease (GERD) do not derive benefit from acid suppression. This review outlines a personalized diagnostic and therapeutic approach to GERD symptoms. The Best Practice Advi...

ACR Appropriateness Criteria® Epigastric Pain.
https://doi.org/10.1016/j.jacr.2021.08.006
Journal of the American College of Radiology : JACR; , Vij A et. al.

Nov 20th, 2021 - Epigastric pain can have multiple etiologies including myocardial infarction, pancreatitis, acute aortic syndromes, gastroesophageal reflux disease, esophagitis, peptic ulcer disease, gastritis, duodenal ulcer disease, gastric cancer, and hiatal h...

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Pr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868475
Clinical Pharmacology and Therapeutics; Lima JJ, Thomas CD et. al.

Aug 10th, 2020 - Proton pump inhibitors (PPIs) are widely used for acid suppression in the treatment and prevention of many conditions, including gastroesophageal reflux disease, gastric and duodenal ulcers, erosive esophagitis, Helicobacter pylori infection, and ...

see more →

Drugs  829 results see all →

Clinicaltrials.gov  463 results

Risk Factors and Biomarkers for Diagnosis and Treatment of EoE
https://clinicaltrials.gov/ct2/show/NCT01988285

Mar 22nd, 2023 - Purpose: To validate our previously developed model of risk factors for diagnosis of eosinophilic esophagitis (EoE), and to assess the utility of serum levels of biomarkers in diagnosis and monitoring of treatment of EoE. Participants: Up to a tot...

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
https://clinicaltrials.gov/ct2/show/NCT01011712

Mar 17th, 2023 - Viral infections in the normal host are usually self-limited as the innate and acquired immune systems mount successful antiviral responses. However, in some instances, apparently immunocompetent persons manifest infections with viruses that would...

A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis
https://clinicaltrials.gov/ct2/show/NCT04682639

Mar 13th, 2023 - The purpose of this study is to determine whether oral etrasimod is a safe and effective treatment for active eosinophilic esophagitis (EoE) in adult participants.

A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
https://clinicaltrials.gov/ct2/show/NCT04753697

Mar 10th, 2023 - Study CC-93538-EE-001 is a Phase 3, multicenter, multinational, randomized, double-blind, placebo-controlled induction and maintenance study to evaluate the efficacy and safety of CC- 93538 in adult and adolescent participants with eosinophilic es...

Effect of MIST on Esophageal Sensitivity: Pilot Study
https://clinicaltrials.gov/ct2/show/NCT05760872

Mar 8th, 2023 - Gastro-esophageal reflux disease (GERD), defined as the presence of symptoms or lesions that can be attributed to the reflux of gastric contents into the esophagus, is an increasingly prevalent condition in Western societies. The most typical symp...

see more →

News  512 results

Dupilumab moves forward as possible COPD treatment
https://www.mdedge.com/chestphysician/article/262062/copd/dupilumab-moves-forward-possible-copd-treatment
Heidi Splete, MDedge News

Mar 28th, 2023 - Dupilumab, a fully human monoclonal antibody, significantly improved quality of life and respiratory symptoms compared with placebo in a phase 3 trial of more than 900 adults with uncontrolled chronic obstructive pulmonary disease. In the study, k.

EoE: One-food elimination works as well as six-food elimination
https://www.mdedge.com/internalmedicine/article/261622/gastroenterology/eoe-one-food-elimination-works-well-six-food
Carolyn Crist

Mar 7th, 2023 - For adults with eosinophilic esophagitis (EoE), eliminating animal milk alone appears to be as effective for treating the disease as forgoing milk and five other foods, according to a new report. A one-food elimination diet (1FED) led to histologi.

Avoiding Just This Dietary Trigger Helps Resolve Eosinophilic Esophagitis
https://www.medpagetoday.com/allergyimmunology/allergy/103343

Mar 1st, 2023 - A one-food elimination diet (1FED) could be just as effective as the popular six-food elimination diet (6FED) for patients suffering from eosinophilic esophagitis (EoE), a randomized trial showed. Removing animal milk alone led to histological rem...

Immune checkpoint inhibitor–related gastrointestinal adverse events
https://www.mdedge.com/gihepnews/article/260550/mixed-topics/immune-checkpoint-inhibitor-related-gastrointestinal-adverse
Joshua Kwon, MD, Paul T. Kröner, MD, MSc

Jan 11th, 2023 - Introduction The field of cancer immunotherapy has exploded in recent years, with new therapies showing promising results for effective treatment of various cancer types. Immune checkpoint inhibitors (ICI) work by blocking checkpoint proteins that.

Data on Dupixent in Eosinophilic Esophagitis Now Published
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/102355

Dec 21st, 2022 - Dupilumab (Dupixent) was superior to placebo in the phase III trial underpinning its approval last spring for eosinophilic esophagitis (EoE), researchers said. About 60% of patients receiving the active drug -- a monoclonal antibody targeting inte...

see more →

Patient Education  41 results see all →